[HTML][HTML] Formulation and evaluation of eudragit RL-100 nanoparticles loaded in-situ forming gel for intranasal delivery of rivastigmine

S Salatin, J Barar, M Barzegar-Jalali… - Advanced …, 2020 - ncbi.nlm.nih.gov
prepared using different polymer to drug ratios and evaluated for their physicochemical
characteristics… PF-127 nanoformulations were prepared via cold method and analyzed in terms of …

[HTML][HTML] Advances on therapeutic strategies for Alzheimer's disease: from medicinal plant to nanotechnology

NA Hassan, AK Alshamari, AA Hassan, MG Elharrif… - Molecules, 2022 - mdpi.com
Alzheimer’s disease (AD) is a chronic dysfunction of neurons in the brain leading to dementia.
It is characterized by gradual mental failure, abnormal cognitive functioning, personality …

From adsorption to covalent bonding: Apolipoprotein E functionalization of polymeric nanoparticles for drug delivery across the blood–brain barrier

N Hartl, F Adams, OM Merkel - Advanced therapeutics, 2021 - Wiley Online Library
… Loperamide-loaded PLGA–PEG–PLGA (PEP) NPs were prepared by a nanoprecipitation …
Tacrine and rivastigmine-loaded polysorbate 80-coated PBCA NPs were applied to healthy …

[HTML][HTML] Targeting systems to the brain obtained by merging prodrugs, nanoparticles, and nasal administration

G Botti, A Dalpiaz, B Pavan - Pharmaceutics, 2021 - mdpi.com
… as very useful to optimize the encapsulation of neuroactive drugs … the prodrug approach can
allow optimization of the nasal … -coated PBCA or poloxamer 188-coated PLGA nanoparticles

Controlled release and targeted drug delivery with poly (lactic-co-glycolic acid) nanoparticles: reviewing two decades of research

A Zeb, M Gul, TTL Nguyen, HJ Maeng - Journal of Pharmaceutical …, 2022 - Springer
optimization and modifications are necessary to achieve the desired characteristics of PLGA-…
A detailed summary of the most widely used preparation techniques for PLGA-NPs, along …

Flavonoid-based nanomedicines in Alzheimer's disease therapeutics: Promises made, a long way to go

P Prasanna, A Upadhyay - ACS Pharmacology & Translational …, 2021 - ACS Publications
… For instance, the development of polysorbate 80 coated poly n-butylcyanoacrylate (PBCA)
and poly lactic-co-glycolic acid (PLGA) nanoparticles loaded with drug molecules like …

Riluzole-loaded nanoparticles to alleviate the symptoms of neurological disorders by attenuating oxidative stress

B Nabi, S Rehman, M Fazil, S Khan… - Drug development and …, 2020 - Taylor & Francis
… The optimized RIZ CSNPs was further functionalized using Tf … A-loaded PLGA nanoparticles
with surface modification by … The characterization of the prepared RIZ CSNPs and RIZ-Tf …

[HTML][HTML] Oral dissolving film of rivastigmine: optimization using factorial design

DA Farghaly, SA Afifi, AA Aboelwafa… - Journal of …, 2023 - Springer
… Data analysis was done by applying one-way analysis of variance (ANOVA) followed by
Tukey test. A value of p < 0.05 was considered significant. The “Graph Pad InStat Demo v.” …

Basics of Targeted Drug Delivery

KA Doshi - Targeted Drug Delivery, 2022 - Wiley Online Library
rivastigmine-loaded poly(lactide-co-glycolide) (PLGA) and polysorbate 80 (PBCA-80)-coated
poly(n-butylcyanoacrylate) nanoparticle … : preparation, optimization, characterization, in …

[HTML][HTML] Polysorbate-based drug formulations for brain-targeted drug delivery and anticancer therapy

V Ravichandran, M Lee, TG Nguyen Cao, MS Shim - Applied Sciences, 2021 - mdpi.com
Rivastigmine-loaded PBCA NPs have been developed for the … ) (PLGA) NPs were prepared
to increase the localization of acetylpuerarin (AP) in the brain of mice [133]. AP-loaded PLGA